Stock Options - Schedule of Stock Option Activity (Details) |
6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
|
Apr. 30, 2026
USD ($)
shares
|
Oct. 31, 2025
USD ($)
shares
|
Oct. 31, 2025
$ / shares
|
Apr. 30, 2026
$ / shares
|
|
| Schedule of Stock Option Activity [Abstract] | ||||
| Shares, Outstanding ending balance | shares | 4,725,000 | |||
| Weighted Average Exercise Price, Outstanding ending balance | $ / shares | $ 0.23 | |||
| Weighted Average Remaining Contractual Life (Years), Outstanding ending balance | 2 years 3 months 29 days | |||
| Aggregate Intrinsic Value, Outstanding ending balance | $ | $ 225,870 | |||
| Shares, Outstanding and exercisable | shares | 4,725,000 | |||
| Weighted Average Exercise Price, Outstanding and exercisable | $ / shares | $ 0.23 | |||
| Weighted Average Remaining Contractual Life (Years), Outstanding and exercisable | 1 year 9 months 29 days | |||
| Aggregate Intrinsic Value, Outstanding and exercisable | $ | $ 867,036 | |||
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for vested portion of option outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|